ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

BACKGROUND: Polymorphisms in the excision repair cross-complimentary group 1 (ERCC1) gene have been involved in the prognosis of various cancers. In the present study, we evaluated the prognostic role of the two most common ERCC1 polymorphisms in patients with T4 breast cancer receiving platinum-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177579/
https://www.ncbi.nlm.nih.gov/pubmed/25253066
http://dx.doi.org/10.1186/s12967-014-0272-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177579/
https://www.ncbi.nlm.nih.gov/pubmed/25253066
http://dx.doi.org/10.1186/s12967-014-0272-4

Ejemplares similares